 <h1>Drisdol Side Effects</h1><p class="drug-subtitle"><b>Generic Name:</b> <i>ergocalciferol</i></p><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li></ul><p class="ddc-notification"><b>Note:</b> This document contains side effect information about ergocalciferol. Some of the dosage forms listed on this page <em>may not</em> apply to the brand name Drisdol.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to ergocalciferol: oral capsules and solution</i></p><p>Side effects include:</p><p>Possible hypervitaminosis D effects: polyuria,  nocturia,  polydipsia,  hypercalciuria,  reversible azotemia,  hypertension,  nephrocalcinosis,  generalized vascular calcification,  irreversible renal insufficiency (may be fatal),  mental retardation,  widespread soft tissue calcification,  osteoporosis,  dwarfism,  vague aches,  stiffness,  weakness,  nausea,  anorexia,  constipation,  mild acidosis,  anemia,  weight loss. </p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to ergocalciferol: compounding powder, injectable solution, oral capsule, oral solution, oral tablet</i></p><h3>Metabolic</h3><p><b>Rare</b> (less than 0.1%): Hypercalcemia</p><p><b>Frequency not reported</b>: Hypervitaminosis D<sup>[Ref]</sup></p><p>Hypervitaminosis D is characterized by: impairment of renal function with polyuria, nocturia, polydipsia, hypercalciuria, reversible azotemia, hypertension, nephrocalcinosis, generalized vascular calcification, or irreversible renal insufficiency which may result in death; intellectual disability; widespread calcification of the soft tissues, including the heart, blood vessels, renal tubules, and lungs; bone demineralization (osteoporosis) in adults; decline in the average rate of linear growth and increased mineralization of bones in infants and children (dwarfism), vague aches, stiffness, and weakness; nausea, anorexia, constipation; and mild acidosis, anemia, and weight loss.<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Rare</b> (less than 0.1%): Hypercalciuria<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Rare</b> (less than 0.1%): Pruritus, rash, urticaria<sup>[Ref]</sup></p><p id="ref_1">1. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_2">2. "Product Information. Drisdol (ergocalciferol)." sanofi-aventis, Bridgewater, NJ. </p><h2>More about Drisdol (ergocalciferol)</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy</li>
<li>Dosage Information</li>
<li>Drug Images</li>
<li>Drug Interactions</li>
<li>Compare Alternatives</li>
<li>Pricing &amp; Coupons</li>
<li>En Espa√±ol</li>
<li>Generic Availability</li>
<li>Drug class: vitamins</li>
<li>FDA Alerts (1)</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Hypoparathyroidism</li>
<li>Familial Hypophosphatemia</li>
<li>Hypocalcemia</li>
<li>Hypophosphatemia</li>
<li data-more-config-id="list-data-resources-conditions">... +5 more</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>